All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
European vs. U.K.: Impacts on Homeopathic Products Worldwide
I've been very fortunate during my career, travelling the world, meeting incredible people and working on projects across the globe. For sure, there can...
FDA Warning Letter Lessons?
By Eric L. Foxman, R.PH., AAHP Secretary Of all the Warning Letters issued by the FDA, very few go to homeopathic manufacturers or marketers. That's...
2020 Presidential & Congressional Elections: Outcome and Agenda Outlook in the 117th Congress
By Pete Evich, AAHP Regulatory Affairs Presidency and Congress President-elect Joe Biden managed to defeat an incumbent president — the first time that’s happened...
2020: A Year of Resiliency and Determination
By Mark Land, AAHP President As remarkable as the limitations of this pandemic year have been, I am also astonished by the resiliency of people,...
How Real-World Data Is Impacting Health Care Decisions Today
By Mark Land, AAHP President I have been interested in the application of Real-World Data (RWD) and Real-World Evidence (RWE) for some time now. Originally,...
Homeopathic Process Validation for Beginners
Consistent, effective, high-quality homeopathic products. That’s what our consumers want in each and every dose. Yet quality doesn’t happen by accident. Manufacturers must create it...
Rite Aid’s Focus on Health and Wellness: What Homeopathy Can Learn
By Ray Petrick, VP of Sales, Boiron USA The U.S. health care market is evolving from an expensive, volume acute-care model to a cost-conscious,...